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Abstract
The recognition of the importance of mRNA turnover in regulating eukaryotic gene expression has
mandated the development of reliable, rigorous, and “user-friendly” methods to accurately measure
changes in mRNA stability in mammalian cells. Frequently, mRNA stability is studied indirectly by
analyzing the steady-state level of mRNA in the cytoplasm; in this case, changes in mRNA abundance
are assumed to reflect only mRNA degradation, an assumption that is not always correct. Although
direct measurements of mRNA decay rate can be performed with kinetic labeling techniques and
transcriptional inhibitors, these techniques often introduce significant changes in cell physiology.
Furthermore, many critical mechanistic issues as to deadenylation kinetics, decay intermediates, and
precursor-product relationships cannot be readily addressed by these methods. In light of these
concerns, we have previously reported transcriptional pulsing methods based on the c-fos serum-
inducible promoter and the tetracycline-regulated (Tet-off) promoter systems to better explain
mechanisms of mRNA turnover in mammalian cells. In this chapter, we describe and discuss in detail
different protocols that use these two transcriptional pulsing methods. The information described
here also provides guidelines to help develop optimal protocols for studying mammalian mRNA
turnover in different cell types under a wide range of physiologic conditions.
1. Introduction
Regulation of mRNA turnover in the cytoplasm is important for controlling the abundance of
cellular transcripts and, in turn, the levels of protein expression (for reviews, see Parker and
Song [2004] and Wilusz et al. [2001]). mRNA stability can be regulated at different levels.
Under a given physiologic condition, mRNAs display a wide range of stability. For example,
c-fos proto-oncogene transcript is degraded rapidly in the cytoplasm with a half-life of 10 to
15 min (Shyu et al., 1989; Treisman, 1985), whereas globin mRNA is rather stable and has a
half-life of several hours in the same cells (Shyu et al., 1989). Although each individual mRNA
has its intrinsic stability under a given condition, stability of an individual mRNA may change
in response to a variety of extracellular stimuli. Examples include the autoregulated
degradation of tubulin mRNA in response to changes in tubulin concentration (Yen et al.,
1988), the iron-dependent destabilization of transferrin receptor mRNA (Casey et al., 1988;
Muellner et al., 1989), the DNA synthesis-dependent destabilization of histone mRNA (Pandey
and Marzluff, 1987), and the stabilization of lymphokine mRNAs by costimulatory molecules
(Lindsten et al., 1989). Thus, modulation of mRNA stability provides a powerful means for
controlling gene expression during the cell cycle, cell differentiation, the immune response, as
well as many other physiologic transitions.
In mammalian cells, the first major step that triggers mRNA decay is deadenylation (i.e.,
removal of the 3′-poly(A) tail). All major mRNA decay pathways recognized in mammalian
cells, including mRNA decay directed by AU-rich elements (AREs) in the 3′-untranslated
region (UTR) (Chen and Shyu, 1995), decay mediated by destabilizing elements in protein-
coding regions (Grosset et al., 2000), nonsense-mediated mRNA decay (NMD) (Chen and
Shyu, 2003), decay directed by microRNAs (miRNAs) (Wu et al., 2006), and decay of stable
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mRNAs such as β-globin mRNA (Loflin et al., 1999a; Shyu et al., 1991), are initiated with
deadenylation. Mammalian deadenylation exhibits biphasic kinetics. During the first phase,
PAN2 poly(A) nuclease, presumably complexed with PAN3, shortens the poly(A) tails to ~110
A nucleotides (nt) (Yamashita et al., 2005). In the second phase, the CCR4-CAF1 poly(A)
nuclease complex further shortens the poly(A) tail to oligo(A) (Yamashita et al., 2005).
Decapping mediated by the DCP1-DCP2 complex was found to occur after either the first or
the second phase of deadenylation (Yamashita et al., 2005). The RNA body can be degraded
by the exoribonuclease XRN1 from the 5′-end after decapping (Parker and Song, 2004).
Alternately, the mRNA body can also be degraded from the 3′-end after deadenylation by a
large protein complex termed the exosome (Parker and Song, 2004).
To unravel the underlying processes of regulated mRNA turnover, a detailed analysis of the
major components involved in mRNA turnover is required. The observation that deadenylation
is the major trigger for cytoplasmic mRNA degradation in mammalian cells underscores the
necessity of explaining the deadenylation step in the process of mRNA turnover. Thus,
determination and characterization of the decay mechanisms demand that mRNA decay
kinetics and precursor-product relationships be accurately and readily monitored
experimentally. The primary emphasis of this chapter is to describe two inducible promoter
systems as examples to illustrate how mRNA turnover may be optimally investigated in
mammalian tissue culture cells with transient transfection systems. Detailed step-by-step
protocols are given so that the half-lives of mRNAs of interest can be determined with
experimental systems described here.
2. General Considerations of mRNA Half-Life Measurements
Messenger RNA stability is often studied indirectly by monitoring changes in the steady-state
level of mRNA in the cytoplasm. However, changes in mRNA abundance are not necessarily
caused by alterations in mRNA stability. For example, mRNA biogenesis in the nucleus (such
as transcription, RNA processing, and/or mRNA export) may be fortuitously altered because
of changes of the physiologic condition or in response to the environmental stimuli. Thus,
alterations in the steady-state level of mRNA may not reflect the changes in mRNA stability.
Direct measurements of decay rates of endogenous mRNAs have been performed in a number
of ways, including kinetic labeling techniques and the use of transcriptional inhibitors.
However, these techniques often introduce significant changes in cell physiology, thereby
perturbing the stability of many mRNAs that could potentially lead to secondary consequences
on the stability of the tested mRNA (e.g., see Belasco and Brawerman [1993], Harrold et al.
[1991], and Ross [1995]). As a result, decay rates obtained in experiments that use these
methods may not reflect the true stability of the mRNAs.
Aside from the methods described previously for measuring endogenous mRNA stability, one
can determine the half-life of an mRNA of interest by transiently transfecting the reporter gene
into mammalian tissue culture cells and using a transcriptional pulsing approach to monitor
deadenylation and decay kinetics of the reporter transcript without the use of a global
transcription inhibitor (Loflin et al., 1999b; Xu et al., 1998). We will detail the procedures and
applications of two transcriptional pulsing systems and discuss the advantages of these systems
over other methods in terms of investigating mRNA turnover in mammalian cells.
3. Determining mRNA Decay Constant
The turnover rate or stability of mRNA in vivo is usually reported as the time required for
degrading 50% of the existing mRNA molecules (i.e., the half-life of mRNAs). Before the half-
life of a given message can be calculated, the decay rate constant must be determined. Assuming
an ideal in vivo situation, in which transcription of the mRNA of interest can be turned off
completely (or at least to an undetectable level), mRNA decay follows first-order kinetics. The
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rate of disappearance of mRNA concentration at a given time (dC/dt) is proportional to both
the rate constant for decay (kdecay) and the cytoplasmic concentration of the mRNA (C). This
relation is described by the following equation:
(17.1)
The minus symbol indicates that the mRNA is being degraded rather than synthesized. This
relationship leads to the derivation of the equation:
(17.2)
where C0 is the concentration of the mRNA at time 0, before decay starts.
Because we want to determine the half-life (t1/2), this means C/C0 = 50%/100% = 1/2.
Rearrangement of equation (17.2) leads to the following equation:
from where:
(17.3)
It is important to note that the half-life of an mRNA (t1/2) is inversely proportional to its decay
rate constant (kdecay).
In a typical time-course experiment, determination of mRNA half-life begins with the analysis
of several RNA samples collected at time intervals, and monitoring the loss of a particular
message by analyzing equal amounts of these samples with two message-specific probes, one
specific for the message of interest and the other specific for an internal control, used to
normalize the data and calculating the half-life of the message of interest (Belasco and
Brawerman, 1993). With linear regression (least-square) analysis to identify the line that best
fits the data, the decay rate constant is obtained from the slope of a semilogarithmic plot of
mRNA concentration (C) as a function of time (t). The half-life (t1/2) can then be calculated
with equation (17.3).
The congruity of mRNA decay to first-order kinetics implies that mRNA molecules of a given
type that differ in age are recognized and targeted for degradation in the same way by cellular
decay machinery. Although this generally seems to be the case in prokaryotes (Belasco and
Higgins, 1988), it is now clear that the deadenylation step is the major step that triggers mRNA
decay and determines the ultimate stability of many mRNAs in both yeast and mammalian
cells (reviewed in Meyer et al. [2004] and Parker and Song [2004]). Therefore, in eukaryotic
cells, many labile or stable mRNAs undergo a period of poly(A) tail shortening during which
there is no apparent decay of the transcribed portion of mRNA (e.g., Chen and Shyu [1994]
and Muhlrad et al. [1994]). Only after the poly(A) tail is shortened to a certain extent, usually
between 10 and 60 nt, does first-order decay of the RNA body ensue. Consequently, eukaryotic
mRNAs decay with biphasic kinetics, composed of an initial lag phase during which
deadenylation occurs and a second phase during which the body of the mRNA is degraded. As
a result, an RNA lifetime cannot meaningfully be described merely in terms of a half-life that
obeys first-order kinetics. This caveat concerning decay kinetics further underscores the
necessity of monitoring the deadenylation step with a transcriptional pulsing approach.
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4. Methods for Measuring mRNA Half-Life
4.1. General inhibition of transcription
A relatively simple way of analyzing mRNA kinetics involves blocking cellular transcription
with inhibitors that include actinomycin D (which interferes with transcription by intercalating
into DNA) or 5,6-dichloro-1β-1-ribofuranosylbenzimidazole (DRB) (which interacts directly
with the RNA polymerase II transcription apparatus) (Harrold et al., 1991). Typically, either
actinomycin D (at a concentration of 5 to 10 μg/ml) or DRB (at a final concentration of 20
μg/ml) is added to cells, and the amount of a particular mRNA remaining at various times of
treatment is used to calculate the mRNA decay rate. The advantage of this approach is that
exogenous genes do not have to be constructed and introduced into cells, and it is an easy way
of measuring stability changes of endogenous mRNAs. However, this method suffers the
disadvantage that both drugs have a profound impact on cellular physiology and, in fact, have
been shown through the years to alter the stability of many mRNAs (Chen et al., 1995; Harrold
et al., 1991; Seiser et al., 1995; Shyu et al., 1989; Speth and Oberbaumer, 1993). Of course,
this complicates interpretation of the data. In addition, monitoring mRNA decay after a
constitutive block in transcription does not allow the determination of deadenylation rates or
precursor-product relationships without the use of supplementary methods. Moreover, for
experiments involving other factors (such as differentiating agents), transcription inhibitors
can result in severe cytotoxicity. These disadvantages limit the application of the seemingly
straightforward and convenient use of transcription inhibitors.
4.2. Use of inducible promoters to specifically promote transient transcription
The use of a regulatable promoter subject to transient induction represents a major
improvement in the analysis of eukaryotic mRNA decay over other methods (Loflin et al.,
1999b). This approach provides a tight and rapid genetic switch to control transcription as
required for studying mRNA turnover without the use of transcription inhibitors. This ensures
that mRNA degradation is investigated under physiologically undisturbed conditions. The
rationale behind this approach, also termed transcriptional pulsing, is rather straightforward:
provide a stimulus that activates transcription and leads to a burst of mRNA synthesis, then
remove the stimulus to shut off transcription and monitor the decay of mRNA. The success of
this method relies on stringent control of the inducible promoter so that induction and silencing
of transcription is accomplished within a narrow window of time. In mammalian cells, the c-
fos promoter has been valuable for this purpose, because it can be induced in response to serum
addition quickly and transiently (Greenberg and Ziff, 1984; Treisman, 1985), thereby providing
a reliable and simple way of achieving a transient burst in transcription. A more recently
developed tetracycline (Tet) regulatory promoter system (Gossen et al., 1993) offers an
alternate strategy that further broadens the application of the transcriptional pulsing approach
to study mRNA turnover in mammalian cells. The two systems are presented in the following
sections.
4.2.1. The c-fos serum-inducible promoter system—Our laboratory has extensively
used the c-fos inducible promoter system to investigate mRNA degradation mediated by AREs
in mouse fibroblast NIH3T3 cells (e.g., see Chen et al. [1994], Chen and Shyu [1994], and
Grosset et al. [2000]). AREs are found within the 3′ UTRs of many unstable mRNAs and
represent the most commonly found RNA destabilizing elements in mammals (Chen and Shyu,
1995; Wilusz et al., 2001). To explain the key functional features of AREs that constitute their
destabilizing ability and to decipher the deadenylation and decay kinetics of ARE-containing
mRNAs, we first made a chimeric reporter construct. This construct contains a rabbit β-globin
gene under the transcriptional control of a 710-base pair (bp) promoter region from the human
c-fos proto-oncogene (Shyu et al., 1989). The β-globin gene was chosen because it encodes a
stable mRNA having a half-life of more than 8 h in NIH3T3 cells (Shyu et al., 1989; 1991).
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This magnitude of stability facilitates detecting an mRNA destabilizing effect that is mediated
by a potential destabilizing element that is experimentally introduced into the β-globin gene.
After individually introducing test destabilizing sequences into the β-globin plasmid construct,
the construct is delivered to cells by transient transfection. Cells are subsequently serum starved
to make them quiescent. After >25 h, β-globin gene transcription driven by the c-fos promoter
is transiently induced by the addition of serum, which returns to an inactive state after an
additional 30 to 40 min (Greenberg and Ziff, 1984; Treisman, 1985). This results in a short
burst of chimeric β-globin mRNA synthesis, after which chimeric β-globin mRNA decay can
be monitored without the use of transcription inhibitors. To do so, RNA samples are collected
at different time points after serum induction, and the decay rate of the chimeric β-globin
mRNAs is determined by Northern blot analysis for example (Shyu et al., 1991).
During the time course experiments, in addition to mRNA decay rates, highly synchronized
poly(A) shortening has been observed, which makes an unequivocal determination of
deadenylation status possible (e.g., see Chen et al. [1994] and Shyu et al. [1991]). Therefore,
many critical mechanistic issues, such as deadenylation kinetics, the existence of decay
intermediates, and precursor-product relationships can also be readily addressed by this method
(Yamashita et al., 2005). In addition, this system is efficient and reproducible, and by allowing
the analysis of transcripts that derive from transiently introduced genes, it eliminates the need
to establish stably transfected cell clones.
Here, we describe two different protocols for the time-course experiments that our laboratory
has been using. The first one is highly cost-effective, which involves calcium phosphate-based
transient transfection of NIH3T3 cells and RNA extraction without the use of a commercial
RNA purification kit. The second protocol uses Lipofectamine 2000 (Invitrogen) for
transfection and RNeasy RNA preparation kit (QIAGENE) for RNA purification.
4.2.1.1. Protocol I: Transient transfection and serum induction: 4.2.1.1.1. Materials: All
solutions should be prepared with extremely pure, glass-distilled water.
1. 2 M CaCl2: Weigh 14.7 g of CaCl2 in a 50-ml conical centrifuge tube and bring H2O
to 50 ml. Dissolve well and use Acrodisc (0.2 μ) to filter-sterilize it. Aliquot the
solution to 1.5 ml microcentrifuge tubes and store at −20 °C.
(Note: Different sources and lot numbers of calcium chloride may affect the timing
and fineness of the calcium phosphate/DNA precipitate that results, thereby affecting
transfection efficiency greatly. More efficient transfection is achieved with fine
precipitates.)
2. 2× HBS: NaCl, 274 mM; KCl, 10 mM;Na2HPO4, 1.4 mM; glucose, 15 mM; HEPES,
42 mM. Adjust the pH of the solution with NaOH precisely to 7.02. Filter sterilize
and aliquot the final solution into 15-ml conical centrifuge tubes and store at 4 °C.
(Note: It is recommended that pH should be checked with two different meters. pH
drift to the acidic end will, in subsequent steps, prevent the formation of the fine
calcium phosphate/DNA precipitate that gives the solution an opaque look, whereas
pH drift to the alkaline end will lead to quick formation of visible calcium phosphate/
DNA clumps. Both situations can lower the transfection efficiency by an order of
magnitude.)
3. DNA solution: The final concentration of DNA (including the test DNA, control
DNA, and carrier DNA) should be 20 μg/0.1 ml in H2O for a 10-cm cell culture dish.
This is made up by empirically determining the optimum amount of transfecting DNA
and adding enough carrier DNA to make a total of 20 μg.
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(Note: We have been using plasmid vectors as carrier DNA [e.g., pUC18]. We usually
use 2 to 3 μg of test DNA [e.g., pBBB + ARE] or its derivatives (Chen and Shyu,
1994; Chen et al., 1994). This amount of DNA seems sufficient to result in the
production of an mRNA signal that can be readily detected by RNA blot analysis with
an exposure time to X-ray film between 3 and 18 h. We have noticed that when more
than 5 μg of test DNA is used in transient transfections, somehow mRNA decay is
retarded. For example, instead of degrading with a half-life of 35 min, BBB + ARE
mRNA displays a 2- to 3-h half-life. This might represent saturation of the decay
machinery.)
4. Bottled Dulbecco’s modified Eagle’s medium (DMEM), calf serum, L-glutamine (1
mM final concentration), and 1% of penicillin-streptomycin (prepared with 10,000
units/ml penicillin G sodium and 10 mg/ml streptomycin sulfate in 0.85% saline).
Note that all the reagents described here are purchased from GIBCO.
5. 1× Phosphate-buffered saline (PBS).
1. 2 × 106 cells are plated in a 10-cm tissue culture dish 16 to 20 h before transfection
and kept in a 5% CO2 incubator.
2. Prepare calcium phosphate/DNA mixture by combining in the following order (for
each plate):
100 μl DNA (20 μg) in H2O
100 μl 2× HBS
916 μl 1× HBS
Then add 84 μl of 2 M CaCl2 solution and mix gently by inverting the tube. Let the mixture sit for 20 min at room temperature.
(Note: If more than one plate is to be transfected, simply multiply each component
by the total number of plates and mix them in a 50-ml conical tube. The mixture should
become a little opaque right after mixing, and 20 min later it should become fairly
opaque, but no precipitation should been seen at this point. Otherwise, the transfection
may not work, and we suggest that the pH of HBS solution should be rechecked.)
3. Add 1.2 ml DNA/calcium phosphate mixture directly to the cells that have been
incubated in a 5% CO2 incubator (from step 1) and gently swirl the plate to mix well
and then immediately return the plate to the 5% CO2 incubator.
(Note: Do not move the plates from the 5% CO2 incubator to the tissue culture hood
until ready to add the DNA/calcium phosphate mixture, because the pH of the culture
medium will increase because of evaporation of CO2 when plates are outside the
incubator. In a high pH environment, the DNA/calcium phosphate mixture will form
coarse precipitates that aggregate into large clumps in the medium. As a result, the
transfection efficiency will be significantly reduced. Also, it is important to not swirl
the plates again once they are put in the incubator. After a 2-h incubation when
examined under the light microscope (20×), one should expect to see fine precipitate
of DNA in the culture medium as many tiny black dots. If DNA precipitates can not
be seen or form clumps, quit the experiment and check the quality of reagents used
as described previously.)
4. Serum starvation
Twelve to 18 h after transfection, aspirate the medium from the dish and rinse the
cells with 5 ml of 1× PBS gently but thoroughly twice. Add 10 ml of DMEM with
only 0.5% calf serum and incubate cells in an 8.0% CO2 incubator for 25 h.
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(Note: It is normal to see some dead cells floating after 25 h of serum starvation.)
5. Serum induction
After serum starvation for 25 h, remove culture medium from the dish and add 10 ml
of fresh culture medium containing 20% calf serum. Harvest cells at desired time
points for RNA purification.
(Note: We routinely obtained 25 to 35% transfection efficiency with NIH3T3 cells
following the preceding protocol.)
4.2.1.2. RNA extraction and Northern blot analysis: 4.2.1.2.1. Materials:
1. NP-40 lysis buffer:
 10 mM Tris-Cl, 7.4
 10 mM NaCl
 3 mM MgCl2 0.5 %NP-40 (v/v) (may be sold under the trade name IGEPAL CA-630)
2. 2× PK buffer:
 200 mM Tris-Cl, 7.5
 440 mM NaCl
 25 mM EDTA
 2% SDS (w/v)
(Note: Both solutions should be autoclaved before use.)
A. On ice or at 4 °C
1. Chill culture dishes (6 to 7 × 106 cells per dish) on ice for 2 to 3 min. Aspirate
the medium and wash cells twice with 3 ml of ice-cold 1× PBS.
2. Add 3 ml ice-cold 1× PBS and scrape off cells with a rubber policeman.
Transfer cells to a 15-ml disposable conical tube. Salvage the remaining cells
with 3 ml 1× PBS.
3. Pellet cells at 4 °C, 300g for 5 min.
4. Remove the supernatant, and loosen the cell pellet in the remaining PBS by
finger vortexing gently.
5. Vortex at half-maximal speed as the 200 μl of NP-40 lysis buffer is added.
Then vortex at the same speed for another 10 sec.
6. Incubate the lysed cells on ice for 5 min. Centrifuge at 4 °C, 300g for 5 min
to pellet nuclei.
7. Transfer supernatant to a 1.5-ml microfuge tube containing 10 μl of
ribonucleoside-vanadyl complex (200 mM stock green-black solution; New
England BioLab). Mix well.
(Note: Ribonucleoside-vanadyl complex is a potent inhibitor of various
ribonucleases. Removal of the ribonucleoside-vanadyl complex from the
RNA can be accomplished by adding 10 equivalents of EDTA before ethanol
precipitation.)
8. Centrifuge at 4 °C, 300g for 5 min.
B. At room temperature:
1. Transfer supernatant to a new 1.5-ml microfuge tube containing 200 μl of
2× PK buffer. Then add 10 μl of protease K (20 mg/ml, Roche), mix well,
and incubate at 37 °C for 30 min.
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2. Extract once with phenol-chloroform (P/C) (containing 8-
hydroxyquinoline). Precipitate the RNA with 2 vol of absolute ethanol. Store
at −70 °C 10 to 15 min or at 20 °C overnight. (Note: It is not necessary to
add extra salt for EtOH precipitation.)
3. Pellet RNA in a microfuge at 4 °C at maximal speed, remove supernatant as
much as possible, and dry the pellet.
4. Redissolve the RNA pellet in 300 μl of TE (pH 7.4) buffer. Add 3 μl of 1
M MgCl2. Mix well and add 1 μl of RNase-free DNaseI (10 mg/ml;
Invitrogen).
5. Incubate at 37 °C for 20 min.
6. Add 6 μl of 10% SDS and 12 μl of 0.25 M EDTA. Extract twice with P/C
(containing 8-hydroxyquinoline).
7. Ethanol precipitation, centrifugation, and desiccation of the RNA sample.
8. Resuspend RNA pellet in 100 μl of RNase-free ddH2O. Take 5 μl to read
OD260. Yield of RNA should be approximately 30 to 50 μg per plate. RNA
samples can be stored at −20 °C for several months to 1 y without any
apparent degradation.
(Note: It is extremely important to completely digest the transfected plasmid
DNA that unavoidably exists in the RNA samples. Otherwise, residual
plasmid DNA may be recognized during Northern blot hybridization,
resulting in smeary black-looking lanes after autoradiography. Although
various RNA purification kits are commercially available, we found often
that DNase I-treatment is not very effective with the kits. Therefore, we
highly recommend the protocol described previously for DNase I treatment.)
1. MOPS buffer: 0.2 M MOPS pH7.0, 50 mM Na acetate, 10 mM EDTA.
2. 10× sample loading buffer: 50% glycerol, 1 mM EDTA, 0.4% bromophenol blue
(BPB), 0.4% xylene cyanol.
3. Dextran sulfate prehybridization buffer (approximately 20 ml).
a. 10 ml formamide (deionized and molecular biology grade).
b. 4 ml 5× P buffer (1% BSA, 1% poly-vinylpyrrolidone, 1% Ficoll, 250 mM
Tris pH 7.5, 0.5% sodium pyrophosphate, 5% SDS).
c. 4 ml 50% Dextran sulfate solution (w/v).
d. Mix by inversion and then warm in 42 °C waterbath approximately 10 min
to help dissolve.
e. Add 1.16 g NaCl and mix by inversion until completely Replace in 42 °C
waterbath.
f. Add 2 ml of 1.5 mg/ml sheared salmon sperm DNA (boiled 10 min and
cooled on ice for 5 min).
g. Mix by inversion and use immediately for prehybridization. (Note: set aside
2 to 3 ml for mixing with the P-32 probe [see steps 12 and 13 of “Procedure”
following].)
1. 1.4% agarose/2.2 M formaldehyde gel.
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a. For a 150 ml gel: boil 2.1 g agarose in 123 ml H2O.
b. Cool to 60 °C in waterbath.
c. Add 15 ml 10× MOPS gel buffer and 12 ml formaldehyde.
(Note: Make sure that the pH of formaldehyde is more than 4; pour in hood.
Can put EtBr in gel [e.g., 0.66 μg/ml].)
2. Prepare RNA sample (20 μl per sample) by mixing:
a. RNA (5 to 20 total RNA) in 4.5 μl H2O.
10× MOPS 2.0 μl
Formaldehyde 3.5 μl
Formamide 10.0 μl
b. Incubate 55 to 60 °C for 15 min.
c. Add 2 μl of 10× loading buffer, and load each sample onto gel.
3. Run the gel in 1× MOPS buffer for approximately 3 to 6 h at 5 V/cm. (Approximately
100 to 150 V for 3 to 4 h) or until BPB completely runs into the gel. Be sure to circulate
the buffer (e.g., with a peristaltic pump).
(Note: To obtain a resolution sufficient for detecting changes in deadenylation, we
recommend that the gel be run overnight by lowering the voltage accordingly.)
4. Remove the gel gently, cut out section to be transferred, and rinse it with water in a
large tray two times (15 min each time) to remove formaldehyde.
5. Soak the gel in excess 50 mM NaOH/10 mM NaCl and shake for 30 min.
6. Neutralize the gel by shaking it in 0.1 M Tris (pH 7.5) twice for 15 min each time.
(Note: If the RNA to be transferred is relatively small (<2.0 Kb), then omit steps 5
and 6.)
7. Soak the gel in 20× SSC for 1 to 2 h.
8. Blot the gel onto the Gene Screen Membrane (New England Nuclear/DuPont) with
one of the commercial vacuum blotting devices (we use the Stratagene Posiblot) for
up to 2 h.
9. Wash the membrane after transfer with 2× SSC. Illuminate the membrane and gel
with UV to make sure the samples have been transferred. Mark the membrane for the
position of rRNA markers or the orientation of the blot.
10. Place the wet membrane on 3MM and irradiate the side containing RNA with the UV
Stratalinker (Stratagene) with 1 to 2 cycles to covalently cross-link RNA to the
membrane. The wet membrane can directly be subjected to prehybridization.
11. Prehybridize the membrane in 20 ml of dextran sulfate prehybridization buffer with
constant agitation for at least 6 h at 42 °C
12. Prepare probe solution by boiling the probe for 10 min and cooling it immediately on
ice for 5 min before mixing it with 3 ml of prehybridization solution that has been set
aside when preparing the dextran sulfate prehybridization buffer.
13. For hybridization, add the 3 ml of probe solution from step 12 into the prehybridization
buffer, where the membrane has been incubated.
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(Note: The final concentration of the probe should be less than 10 ng/ml in
hybridization solution to avoid high nonspecific background.)
14. Incubate the membrane in hybridization solution with constant agitation for 12 to 16
h at 42 °C.
(Note:Various hybridization buffers are commercially available. They may be used
to shortened the prehybridization and hybridization steps from 18 to 22 h to 5 to 6 h,
in which case the manufacturer’s protocol should be followed for both steps.)
15. Remove hybridization solution and wash the membrane in the following solution and
condition with constant agitation:
a. Wash twice with 100 to 200 ml 2× SSC at room temperature for 10 min.
b. Wash twice with 100 to 200 ml of 2× SSC/1.0% SDS at 65 °C for 15 min.
c. Wash twice with 100 to 200 ml of 0.1× SSC at room temperature for 15 min.
16. If the membrane is to be rehybridized, do not allow the membrane to dry. Leave the
membrane slightly damp and wrap it with plastic wrap before exposure to film for
autoradiography. For long-term storage, the membrane should be stripped of probes
(see step 17 below) and stored after drying at room temperature.
17. For stripping the membrane, incubate the membrane in approximately 200 ml of wash-
off buffer (0.1× Denhardt’s soln/5 mM Tris-Cl (pH8.0)/0.2 mM EDTA/0.05% sodium
pyrophosphate) at 68 °C for 2 h. Change to a fresh buffer after the first hour of
incubation.
1. 2.8 × 106 NIH 3T3 cells maintained in DMEM containing 10% calf serum (GIBCO)
with 1% of l-glutamine (200 mM stock from GIBCO) are plated in a 10-cm tissue
culture dish and kept in an 8.0% CO2 incubator for 18 h, allowing the cells to reach
90 to 95% confluence.
2. Transfect the cells with Lipofectamine 2000 (Invitrogen)/DNA complexes as follows:
a. Dilute 60 μl of Lipofectamine 2000 in 1.5 ml of Opti-MEM I medium
(GIBCO), vortex for 1 sec, and incubate at room temperature for 5 min.
b. Dilute 24 μg of DNA in 1.5 ml of Opti-MEM I medium; vortex for 1 sec.
c. Combine the diluted DNA (from step b) with the diluted Lipofectamine 2000
(from step a), vortex for 10 sec, and incubate for 20 min at room temperature.
3. Add the DNA/Lipofectamine 2000 mixture (total volume 3 ml) gently directly to the
cells. Gently rock the plate back and forth so that the DNA/Lipofectamine mixture
distributes evenly in the dish, which is then incubated in a 5% CO2 incubator.
4. 18 h later, aspirate the medium and add 2 ml of 0.25% trypsin-EDTA (GIBCO).
Incubate the plate in a 5% CO2 incubator at 37 °C for 5 min and then add 3 ml of
DMEM/10% calf serum to stop trypsinization. Harvest the cells by centrifuging at
300g for 5 min.
5. Split 1.5 × 106 cells to several 6-cm tissue culture dishes (Note: the number of dishes
depends on the time points required) in 5 ml of DMEM with 0.5% calf serum, 1% of
l-glutamine (200 mM stock from GIBCO), 1% of penicillin-streptomycin (prepared
with 10,000 U/ml penicillin G sodium (GIBCO), and 10 mg/ml streptomycin sulfate
(GIBCO) in 0.85% saline (GIBCO).
6. Serum starvation: incubate cells in an 8.0% CO2 incubator for 24 h, which will force
cells to enter a quiescent (G0) state.
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7. Serum induction: after serum starvation for 24 h, remove culture medium from the
dish and add 5 ml of fresh culture medium containing 20% calf serum. Harvest cells
at desired time points for RNA purification.
(Note: After serum induction, transcription from the c-fos promoter returns to its
original uninduced level in 30 to 40 min [Greenberg and Ziff, 1984].)
8. Refer to Protocol I for cytoplasmic RNA extraction. Alternately, cytoplasmic RNA
may be extracted with RNeasy RNA preparation kit (QIAGENE) according to
manufacturer’s instruction. RNA samples are analyzed by Northern blotting as
described previously.
4.2.2. The Tet-off regulatory promoter system—Although the c-fos promoter system
has been used with success to investigate the decay kinetics and key features of AREs, the
system has some limitations that prevent it from being used as a more general approach.
Because activation of the c-fos promoter requires serum or growth factor induction of quiescent
cells, this system has restricted the analysis of mRNA degradation to cells undergoing the G0
to G1 transition. In addition, many transformed cell lines cannot be readily forced to enter a
quiescent state by serum starvation. Moreover, the use of serum induction complicates the
analysis of regulatory mechanisms or signaling pathways, which may affect decay of mRNA.
As an effort to develop a general approach that would be more suitable to study the regulatory
aspects of differential and selective mRNA turnover in mammalian cells, we explored the Tet-
regulatory promoter system as an alternative. In this system, a chimeric transcription activator
termed tTA was generated by fusing the DNA-binding domain of the TN10-derived
prokaryotic tetracycline repressor protein (tetR) to the transcription-enhancing domain of
VP16 from herpes simplex virus, which binds and strongly activates a minimal promoter
containing seven tetracycline operator (tetO) sequences in the absence of tetracycline (Gossen
and Bujard, 1992; Gossen et al., 1993). Binding of the tTA to the tetO sequences can be quickly
blocked by tetracycline, preventing the activation of the target promoter.
Although its potential application to address the cytoplasmic mRNA turnover seemed obvious,
we found that simply blocking constitutive transcription of the Tet-regulatory promoter with
tetracycline and then monitoring mRNA decay does not give an accurate measurement of
mRNA half-life. This may be due to saturation of cellular decay machineries by the high level
of constitutive mRNA expression. In mouse NIH3T3 or human K562 cells, steady-state level
of the mRNA driven by the Tet-off promoter is 15- to 30-fold higher than that driven by SV-40
early promoter or CMV promoter (Xu, Loflin, Chen and Shyu, unpublished observations).
Moreover, because of the size, heterogeneity of the poly(A) tails resulting from constitutive
transcription, deadenylation and decay kinetics, and thus the relationship between
deadenylation and decay of the mRNA, cannot be unequivocally determined. In light of these
concerns, we have further optimized the systems by modulating the amount of tetracycline and
the timing of its addition to or omission from culture medium. We were able to induce a short
burst of mRNA synthesis from a reporter gene driven by the Tet-off promoter, which displays
kinetics similar to those of the c-fos promoter system (Xu et al., 1998).
In this section, we describe a transcriptional pulsing approach developed by the tet-regulatory
(Tet-off) system with mouse NIH3T3 cells as an example. With the new strategy, we have
demonstrated that AREs can function in mouse NIH 3T3 fibroblasts under growth arrest and
density arrest states (Xu et al., 1998). More recently, we have successfully used this new
approach to study the destabilizing function of different AREs in various phases of the cell
cycle and during blood cell differentiation (Chen et al., 2007). Furthermore, combining this
approach with small interference RNA (siRNA)-mediated gene knockdown, we were able to
trap different decay intermediates indicative of mechanistic steps of mRNA decay in
mammalian cells (Chen et al., 2007; Yamashita et al., 2005). These in vivo studies demonstrate
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the feasibility of this approach to investigate mechanisms underlying differential and selective
mRNA turnover in mammalian cells.
4.2.2.1. Establishment of mammalian stable cell lines expressing the tTA: The first critical
step toward the successful use of the transcriptional pulsing approach with the Tet-off promoter
to monitor mRNA decay kinetics in mammalian cells is to identify or establish a stable line of
interest that expresses tTA. In our laboratory, we have been using the stable β-globin mRNA
as the reporter message for mRNA turnover study. To adapt this system to Tet regulation, we
have constructed a new β-globin reporter plasmid, designated pTet-BBB (Loflin et al.,
1999a; Xu et al., 1998). The plasmid pTet-BBB contains the β-globin gene under control of
the Tet-off promoter, allowing transcription in the absence of tetracycline. The BglII site in the
3′ UTR of the β-globin gene remains unique in the pTet-BBB, providing a site into which RNA
destabilizing elements, such as different AREs, can be introduced to test their ability to
destabilize β-globin mRNA (Loflin et al., 1999a).
Initially, we attempted to test whether tight regulation of transcription from the Tet-off
promoter may be obtained by transiently cotransfecting both the pTet-BBB + ARE and the
pUHD15-1 plasmid encoding the tTA (Gossen and Bujard, 1992). We observed high basal-
level expression of β-globin mRNA bearing the c-fos ARE (BBB + ARE) in the presence of
tetracycline, indicating inefficient repression when tetracycline was added back to turn off
transcription. In addition, the level of BBB + ARE mRNA expression from the Tet-off promoter
varies considerably depending on the relative amount of pTet-BBB + ARE and the pUHD15-1
plasmids used in the transient transfections. Therefore, we do not recommend transient
cotransfection of the Tet-off promoter-driven reporter plasmid and tTA-encoding plasmid. We
refer readers to our previous publications (Chen et al., 2007; Loflin et al., 1999b) for details
regarding establishing and characterizing tTA-expressing stable lines that are suitable for the
transcriptional pulsing approach.
4.2.2.2. Transcriptional pulse strategy by modulating the amount of tetracycline in
culture medium: To obtain a homogeneous population of mRNA, transcription should
proceed for a period sufficient to produce a detectable signal by Northern blot analysis, yet
brief enough to limit heterogeneity of poly(A) tails. The optimal condition can be determined
by a titration experiment. Various concentrations of tetracycline are included in the culture
medium to test at which concentration the steady-state level of β-globin mRNA transcribed
from the transiently transfected pTet-BBB plasmid will be inhibited >99% compared with that
in the absence of tetracycline (Chen et al., 2007; Loflin et al., 1999b; Xu et al., 1998).
Depending on the cell lines and sources of tetracycline, the appropriate concentration of
tetracycline ranges from 25 ng/ml to 100 ng/ml. After transient transfection of the Tet-off
promoter-driven reporter plasmid, the transfected cells should be kept in culture medium
containing the identified concentration of tetracycline until transcription induction
(transcriptional pulsing). It is striking that all three different mammalian stable lines we
established, including mouse NIH3T3 B2A2, human K562 III-2, and human BEAS-2B-19,
show the same transcriptional pulsing kinetics in Northern blot analysis (Chen et al., 2007;
Loflin et al., 1999b; Xu et al., 1998). A population of mRNA homogenous in size appears in
the cytoplasm after removal of tetracycline for 100 to 110 min, making it possible to study
deadenylation and decay kinetics and precursor and product relationships during mRNA decay.
Typically, the reporter mRNA becomes detectable 90 min after the transfected cells are moved
to fresh medium without tetracycline. After another 20 min (i.e., 110 min pulse), a descent
signal representing a population of mRNAs with poly(A) tails homogeneous in size is
produced. Because this time period is highly reproducible and is also observed in all different
stable clones we have tested, this period has been used in our studies that use the Tet-off
promoter-driven transcriptional pulsing approach and detailed as follows.
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1. After transfection, the cells are grown in 25 to 40 ng/ml tetracycline for a period of
36 to 48 h.
2. Induction of a detectable homogeneous population of β-globin mRNA is
accomplished by shifting the cells to fresh culture medium for 110 min.
3. The pulse is quickly terminated by adding 500 ng/ml tetracycline, and RNA samples
are isolated at various times afterward.
4. Conduct RNA blot analysis as described previously.
Notes: Several experimental details and caveats are important for the success of transcriptional
pulsing strategy. First, the amount of transfected plasmid DNA coding for the reporter mRNA
must be empirically optimized with a positive control coding for an unstable message to avoid
saturation of the decay machinery with excess mRNA. Second, the optimal amount of
transfected DNA may vary when different transient transfection reagents or cells are used and
must be optimized empirically. Third, to detect the mRNA synthesized after the removal of
tetracycline for 110 min (transcriptional pulsing), it is crucial to select a stable tTA-expressing
clone that gives the maximally induced expression level of the reporter gene. Both the NIH3T3
B2A2 and the K562 III-2 clones we selected for our mRNA decay study give more than 109
RLU/mg of protein by luciferase assay in transient transfection experiments (Loflin et al.,
1999b; Xu et al., 1998). Fourth, to accurately determine deadenylation and decay kinetics, a
robust, yet brief, transcription is necessary. Thus, the resumption kinetics of transcription on
the removal of tetracycline displayed by the selected stable line is a crucial factor. For example,
although we were able to identify a few stable clones that overexpress the transfected reporter
genes at an equally high level in the absence of tetracycline, we noticed that not all of them
exhibited fast resumption kinetics of transcription after tetracycline removal (data not shown).
This difference may be derived from variations in copy number and integration site of the tTA
cDNA in stable clones. Because slow resumption kinetics of transcription requires a prolonged
pulse, and thus leads to heterogeneity in the size of mRNA molecules, one should pick a clone
that is able to give at least 10% of the maximal level of expression after the 110-min pulse
period without tetracycline so that a sufficient signal representing an mRNA population
homogeneous in size can be generated for kinetic studies. Last, cells should be continually
maintained in the presence of tetracycline, except for the short period of induction, because
production of tTA for a longer period seems cytotoxic to the cells, and cells that have lost tTA
expression may gradually take over the population during prolonged incubation without
tetracycline. However, this problem may be avoided if one establishes stable lines with a
modified tTA that seems to show little cytotoxicity (Clontech). Also, medium with tetracycline
should always be prepared fresh and kept in the dark at 4 °C. A variety of mammalian cell lines
harboring the tTA gene have been established, and they are commercially available. They may
be tested for appropriateness for mRNA decay kinetic studies as described previously.
1. 2.6 to 2.8 × 106 NIH 3T3 B2A2 cells maintained in DMEM containing 10% calf serum
(Gibco), 1% of l-glutamine (200 mM stock from Gibco), and 100 ng/ml tetracycline
(CalBiochem) are plated in a 10-cm tissue culture dish and incubated in an 8% CO2
incubator.
(Note: In previous publications, we used 25 to 30 ng/ml of tetracycline that was
purchased from Sigma. We found that higher concentration of tetracycline was needed
to achieve the desired transcriptional pulsing when we used the tetracycline purchased
from CalBiochem. Thus, the optimal amount of each critical reagent used in the
experiment should be tested empirically when it is ordered from different companies
or when a new lot is ordered from the same company.)
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2. After 18 to 24 h, when cells reach 90 to 95% confluence, prepare the transfect cells
and Lipofectamine 2000 (Invitrogen)/DNA complexes and harvest cells as described
in Protocol II sections 2 to 4.
3. Split 1.5 × 106 cells to several 6-cm tissue culture dishes (Note: the number of dishes
depends on the need of each experiment) in 5 ml of DMEM with 10% calf serum, 1%
of L-glutamine (200 mM stock from Gibco), 1% of penicillin-streptomycin [prepared
with 10,000 U/ml penicillin G sodium (Gibco) and 10 mg/ml streptomycin sulfate
(Gibco) in 0.85% saline (Gibco), and 100 ng/ml tetracycline (CalBiochem)]. Incubate
cells in an 8.0% CO2 incubator for 24 h.
4. Remove medium and add 5 ml of complete medium without tetracycline to allow
transcription of the reporter gene driven by the Tet-off promoter. Incubate the cells
in an 8.0% CO2 incubator immediately for 110 min.
5. To stop transcription, add complete medium containing tetracycline (500 ng/ml) to
each plate.
6. Refer to Protocol I for cytoplasmic RNA extraction. Alternately, cytoplasmic RNA
may be extracted with RNeasy RNA preparation kit (Qiagen) according to the
manufacture’s instruction. RNA samples are analyzed by Northern blotting as
described previously.
Notes: The same procedure can also be used to introduce DNA and siRNA simultaneously into
NIH 3T3 B2A2 cells. When introducing siRNA together with DNA, up to 320 pmol siRNA
should be diluted in the same tube with 6.5 μg of plasmid DNA and 40 μl of Lipofectamine
2000. The ratio between siRNA and DNA is critical, as increasing siRNA amount may reduce
the transfection efficiency or expression of the reporter DNA. We also refer readers to one of
our previous publications (Chen et al., 2007), in which we describe another protocol that
combines a consecutive siRNA knockdown procedure with plasmid DNA transfection with
transfectants from Qiagen.
4.2.2.4. Directly measuring mRNA half-life with the Tet-off promoter system without
transcriptional pulsing: For studies that do not directly deal with mRNA deadenylation and
decay kinetics or mechanistic steps (e.g., if one wants to investigate whether a known signaling
pathway may alter the stability of the transcript of interest), time-course experiments for
measuring mRNA stability can be done without the use of the transcriptional pulsing approach.
After transiently transfecting the tTA-expressing cells with the Tet-off promoter-driven
reporter plasmid, cells are kept in culture medium without tetracycline to allow constitutive
expression of the reporter mRNA. After 48 h, tetracycline is added to the medium to a final
concentration of 500 ng/ml to stop transcription from the Tet-off promoter and total RNA is
extracted at different time intervals. This approach has been used successfully to study the
stability of mRNAs of interest in the presence or absence of a stimulus known to activate a
desired signaling pathway (Winzen et al., 1999), as well as to identify stimuli and signaling
pathways that modulate stabilities of several cytokine and chemokine mRNAs during various
immune responses (reviewed in Stoecklin and Anderson [2006]).
One potential caveat when the aforementioned approach is used to directly measure mRNA
half-life is that highly robust and constitutive transcription of the reporter mRNA driven by
the Tet-off promoter may saturate the system, thereby impeding proper decay of the transcript.
We recommend that a titration experiment should be carried out first to identify the optimal
amount of transfecting DNA that does not force the mRNA stabilization but still results in a
signal detectable by Northern blot analysis (e.g., by an overnight exposure of an RNA blot to
X-ray film).
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5. Concluding Remarks
We have described two transcriptional pulsing methods that result in the synthesis of an mRNA
population nearly homogeneous in size. These methods have several advantages over other
approaches used to measure mRNA half-life. They offer the opportunity to determine
deadenylation and decay kinetics, as well as the precursor-product relationship of mRNA
turnover (Yamashita et al., 2005). Although the c-fos promoter system is convenient to quickly
address the mechanistic steps involved and characterize the cis-acting sequences, the Tet-
regulatory system provides the opportunity to study the regulation under physiologically
relevant and undisturbed conditions. For example, the role of mRNA turnover in controlling
the cell cycle can also be studied with the protocol developed with cells arrested at individual
phases of the cell cycle (Chen et al., 2007). In addition, with an increasing collection of tTA-
expressing cell lines, the Tet-regulatory promoter system combined with our strategy allows
the analysis of mRNA turnover and its regulation under various physiologic conditions
including, but not limited to, during cell growth and differentiation, the immune response, and
tissue repair. For instance, with the establishment of the Tet-regulatory promoter system in
lymphoid cell lines or hematopoietic cell lines representing different hematopoietic stages,
explanation of the mechanisms responsible for the regulation of cytokine and chemokine
mRNAs are already underway (Chen et al., 2007).
Recently, we have successfully combined the siRNA-mediated gene knockdown and the
transcription pulsing systems to decipher mechanistic steps in mammalian mRNA turnover
(Yamashita et al., 2005). We showed that deadenylation is the major trigger of mRNA decay
in mammalian cells and that decapping does not occur until or after the second phase of
deadenylation (Yamashita et al., 2005). By use of the approaches and protocols described here,
the applications of transcription pulsing systems can be further expanded to study not only the
mechanistic steps of mRNA decay but also their regulation by trans-acting factors. For
instance, the transcriptional pulsing approach will facilitate our understanding as to how
miRNAs tie into the mRNA decay machinery to accomplish gene silencing in mammalian
cells, because miRNA-mediated mRNA decay also starts with deadenylation (Wu et al.,
2006). The protocols described in this chapter and our approaches to optimize these protocols
provide guidelines for more widespread development of new protocols with transcriptional
pulsing strategies and their applications to study mRNA turnover under various physiologic
conditions.
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